Pakistan Begins Clinical Trial of Chinese Vaccine for COVID-19

Pakistan has begun stage three clinical trials of a China-made COVID-19 vaccine, reports Aamer Ikram, Executive Director of the country's National Institute of Health (NIH).

Pakistan has approved phase three clinical trial of a COVID-19 vaccine developed in collaboration with a Chinese company, reports Executive Director of the country's National Institute of Health (NIH) Aamer Ikram.

While addressing a press conference, the official told the vaccine will be administered to 8,000 to 10,000 volunteers across the country. Its final results are expected to come out in around six months. Pakistan will begin administering it to the general public after the results.

COVID Vaccine Will be Ready by 'Start of Next Year' In India
Union Health Minister Harsh Vardhan on Thursday said that the coronavirus vaccine will be made available in the country by the start of next year.

‘China's CanSino Biologics is developing the COVID-19 vaccine, which is under clinical trial, and Pakistan is among the seven countries which will carry out the phase 3 trials.’

He said the vaccine has already been demonstrated safe on animals, and there are high expectations that it will be proven safe for humans too.

Special Assistant to the country's Prime Minister on National Health Services Faisal Sultan also briefed the media on the vaccine, saying that it will benefit Pakistanis and the world if the clinical trial succeeded.

Sultan said the vaccine trial is a vital step for Pakistan as it will help in the capacity building of the country to develop vaccines against other viral diseases.

Health Experts React To Russian Covid Vaccine Cautiously
Cautiously after the news of Russia registering the world's first Covid-19 vaccine, Indian health experts stressed that it would be too early to say if it is safe or not as adequate testing didn't take place.

The drug regulatory authority of Pakistan approved the vaccine trial, and it will be administered under the supervision of the NIH.

Pakistan has so far reported over 306,000 COVID-19 cases and 6,420 deaths.

Clinical Trials of Covid Vaccine Begins In India
For India's first indigenous Covid-19 vaccine, two volunteers were given its first dose at the Nizam's Institute of Medical Sciences (NIMS) on Monday.

Source-Medindia

COVID Vaccine to Cost Less Than Rs 250/dose: Serum Institute
Serum Institute of India has joined hands with Astra Zeneca and Novavax to develop their COVID-19 vaccine candidates.